company background image
690 logo

Uni-Bio Science Group SEHK:690 Stock Report

Last Price

HK$0.077

Market Cap

HK$474.6m

7D

-7.2%

1Y

28.3%

Updated

27 Mar, 2024

Data

Company Financials

Uni-Bio Science Group Limited

SEHK:690 Stock Report

Market Cap: HK$474.6m

690 Stock Overview

Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

690 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Uni-Bio Science Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Uni-Bio Science Group
Historical stock prices
Current Share PriceHK$0.077
52 Week HighHK$0.11
52 Week LowHK$0.041
Beta-0.21
1 Month Change-13.48%
3 Month Change10.00%
1 Year Change28.33%
3 Year Change-21.43%
5 Year Change-50.00%
Change since IPO-84.15%

Recent News & Updates

Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Jan 22
Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Oct 24
Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Recent updates

Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Jan 22
Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Oct 24
Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)

Apr 30
Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)

We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Nov 22
We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)

Jan 05
Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)

Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth

Mar 01
Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth

Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years

Jan 05
Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years

We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Nov 23
We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Shareholder Returns

690HK BiotechsHK Market
7D-7.2%-5.5%-0.6%
1Y28.3%-41.7%-14.0%

Return vs Industry: 690 exceeded the Hong Kong Biotechs industry which returned -41.9% over the past year.

Return vs Market: 690 exceeded the Hong Kong Market which returned -12.7% over the past year.

Price Volatility

Is 690's price volatile compared to industry and market?
690 volatility
690 Average Weekly Movement10.4%
Biotechs Industry Average Movement9.4%
Market Average Movement7.3%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 690's share price has been volatile over the past 3 months.

Volatility Over Time: 690's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
2001340Frank Zhaohttps://www.uni-bioscience.com

Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China. It operates in Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Boshutai, a small molecule drug to treat diabetes.

Uni-Bio Science Group Limited Fundamentals Summary

How do Uni-Bio Science Group's earnings and revenue compare to its market cap?
690 fundamental statistics
Market capHK$474.60m
Earnings (TTM)HK$63.27m
Revenue (TTM)HK$494.67m

7.5x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
690 income statement (TTM)
RevenueHK$494.67m
Cost of RevenueHK$105.44m
Gross ProfitHK$389.23m
Other ExpensesHK$325.96m
EarningsHK$63.27m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.01
Gross Margin78.68%
Net Profit Margin12.79%
Debt/Equity Ratio4.9%

How did 690 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.